Epithelial-myoepithelial carcinoma of the nasopharynx: cases report and literature review
Our cases illustrate the heterogeneous clinical behavior of nasopharyngeal EMCa, ranging from indolent disease to aggressive progression. Our observations suggest that high <sup>18</sup>F-FDG uptake may serve as a critical biomarker for an aggressive phenotype. Given this variability, individualized treatment strategies may be warranted, and further studies are needed to better define optimal management for this rare tumor.
Authors
- Yuanyuan Zeng (ORCID: https://orcid.org/0000-0002-2260-4468)
- Chenfeng Tan
- Lixue Yin (ORCID: https://orcid.org/0000-0002-9007-1800)
- Zhongzheng Xiang (ORCID: https://orcid.org/0000-0002-4893-7084)
- Wei Xiong (ORCID: https://orcid.org/0000-0001-7719-1712)
- Qingxin Wu (ORCID: https://orcid.org/0000-0003-4017-7110)
- NaNa Wu
- Lei Liu
- Zelei Dai
- Jun Wang
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- First Affiliated Hospital of Chengdu Medical College (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-01-16
- DOI
- https://doi.org/10.3389/fonc.2025.1720988
- Primary Topic
- Salivary Gland Tumors Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00